Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Biostem Technologies

Clinical trials sponsored by Biostem Technologies, explained in plain language.

BioStem Technologies BSEM OTC

Regenerative medicine company developing placental tissue-based products.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 2

Placental patch shows promise for stubborn leg wounds

Disease control Ongoing

This study tests whether a special placental membrane called BR-AC, applied weekly, can help heal non-healing venous leg ulcers faster than standard care alone. About 60 adults with a leg ulcer between the knee and ankle will be randomly assigned to get either standard care plus …

Phase: NA • Sponsor: BioStem Technologies • Aim: Disease control

Last updated Aug 14, 2026 00:00 UTC